Estimation of the cost in the farmacologic treatment of chronic renal failure;El coste del tratamiento farmacológico en la enfermedad renal crónica

Nefrologia

Volumn 26, Issue 3, 2006, Pages 358-364

  Pons, Ramón ^a,b   Torregrosa, E ^a   Hernandez Jaras J ^a   Garcia H ^a   Rius A ^a   Calvo, C ^a   Sanchez Canel J ^a   Pin, M ^a   Maduell, F ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^b Servicio de Nefrologia   (Spain)

Author keywords

Cost; End stage renal disease; Predialysis; Treatment

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COST; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33750585516     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Manns B, Taub K, Donaldson C: Economic Evaluation and End-Stage Renal Disease: from Basics to Bedside. Am J Kid Dis 36: 12-28, 2000.
2. Ploth D, Shepp P, Counts C, Hutchinson F: Prospective Analysis of Global Costs for Maintenance of Patients With ESRD. Am J Kid Dis 42: 12-21, 2003.
3. Hunsicker LG: The consequences and cost of chronic kidney disease before ESRD. J Am Soc Nephrol 15: 1363-1364, 2004.
4. Nota de Prensa del Ministerio de Sanidad y Consumo del 21-feb-05. Página web: http://www.msc.es
5. Steinbrook R: The Prescription-Drug Problem. N Engl J Med 346: 790, 2002.
6. Rodríguez-Carmona A, Pérez Fontán M, Valdés Can̄edo F: Estudio comparativo de costes de las diferentes modalidades de diálisis. Nefrología 16: 539-548, 1996.
7. Martín Hernández R: Aspectos económicos del tratamiento con diálisis de la IRCT. Nefrología 16: 81-92, 1996.
8. Martín Hernández R: Análisis de los costes en nefrología: situación actual y perspectivas de futuro. Nefrología 18: 40-51, 1998.
9. Hernández-Jaras J, García H, Bernat A, Cerrillo V: Aproximación al análisis de costes de diferentes tipos de hemodiálisis mediantes unidades relativas de valor (URV). Nefrología 20: 284-289, 2000.
10. Trivedi H, Pang M, Campbell A y cols.: Slowing the Progression of Chronic Renal Failure: Economic Benefits and Patient's Perspectives. Am J Kid Dis 39: 721-729, 2002.
11. McLaughlin K, Manns B, Culleton B y cols.: An Economic Evaluation of Early Versus Late Referal of Patients With Progressive Renal Insufficiency. Am J Kid Dis 38: 1122-1128, 2001.
12. Peter W, Kahn S, Ebben J, Pereira B, Collins A. Chronic Kidney disease: the distribution of health care dollars. Kidney Int 66: 313-321, 2004.
13. Mendelssohn DC. Coping with the CKD epidemic: the promise of multidisciplinary team-based care. Nephrol Dial Transplant 20: 10-12, 2005.
14. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15: 1300-1306, 2004.
15. London R, Solis A, Goldberg G, Wade S, Ryu S: Health Care Resource Utilization and Impact of Anemia Management in Patients With Chronic Kidney Disease. Am J Kidney Dis 40: 539-548, 2002.
16. London R, Solis A, Goldberg G y cols.: Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population. J Manag Care Pharm 9: 248-255, 2003.
17. Robbins JD, Kim JJ, Zdon G y cols.: Resource use and patient care associated with chronic kidney disease in a managed care setting. J Manag Care Pharm 9: 238-247, 2003.
18. Guías SEN: Rin̄ón y Enfermedad Cardiovascular. Nefrología 24 (Supl. 6), 2004.
19. Mitch WE: Treating Diabetic Nephropathy - Are There Only Economic Issues? N Engl J Med 351: 1934-1936, 2004.
20. Kronick R: Financing Health Care - Finding the Money Is Hard and Spending It Well Is Even Harder. N Engl J Med 352: 1252-1254, 2005.
21. Scherer FM: The Pharmaceutical Industry - Prices and Progress. N Engl J Med 351: 927-932, 2004.